CXCL9 and pancreatic adenocarcinoma: As CXCL9 treatment showed significant suppression on CD8+ population in PAAD tumour, the findings of adoptive transfer suggested that suppression of cytotoxic T cells could be responsible for the tumour-promoting action of CXCL9 in PAAD.